These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23362007)

  • 1. Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men.
    Hetzl AC; Montico F; Lorencini RM; Kido L; Cândido E; Billis A; Ferreira U; Cagnon VH
    Microsc Res Tech; 2013 Mar; 76(3):321-30. PubMed ID: 23362007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptors, matrix metalloproteinases, insulin-like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men.
    Hetzl AC; Fávaro WJ; Billis A; Ferreira U; Cagnon VH
    Microsc Res Tech; 2012 Sep; 75(9):1197-205. PubMed ID: 22648746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol.
    Smith P; Rhodes NP; Ke Y; Foster CS
    Prostate Cancer Prostatic Dis; 2002; 5(2):105-10. PubMed ID: 12496997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.
    Silva MM; Matheus WE; Garcia PV; Stopiglia RM; Billis A; Ferreira U; Fávaro WJ
    Int Braz J Urol; 2015; 41(5):849-58. PubMed ID: 26689510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
    Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
    Wu X; Jin C; Wang F; Yu C; McKeehan WL
    Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin, EGFR, vimentin and α-actin profiles in elderly rat prostate subjected to steroid hormonal imbalance.
    Hetzl AC; Montico F; Kido LA; Cagnon VH
    Tissue Cell; 2016 Jun; 48(3):189-96. PubMed ID: 27021728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate.
    Attia DM; Ederveen AG
    Prostate; 2012 Jun; 72(9):1013-22. PubMed ID: 22025007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence and steroid hormone receptor reactivities in accessory sex glands of elderly rats (Sprague-Dawley) following exogenous hormonal therapy.
    Cândido EM; Fávaro WJ; Montico F; Hetzl AC; Cagnon VH
    Tissue Cell; 2012 Aug; 44(4):227-37. PubMed ID: 22541803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression.
    Huss WJ; Barrios RJ; Foster BA; Greenberg NM
    Prostate; 2003 Jan; 54(1):8-16. PubMed ID: 12481250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
    Fujimura T; Takahashi S; Urano T; Ogawa S; Ouchi Y; Kitamura T; Muramatsu M; Inoue S
    Biochem Biophys Res Commun; 2001 Dec; 289(3):692-9. PubMed ID: 11726203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
    Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.